CI
LLY icon

Corient IA’s Eli Lilly LLY Stock Holding History

Corient IA’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
1,670
+1,000
+149% +$1.02M 1.85% 7
2026
Q1 		$616K Buy
670
+480
+253% +$487K 0.58% 33
2025
Q4 		$204K Sell
190
-1,500
-89% -$1.43M 0.19% 201
2025
Q3 		$1.29M Buy
1,690
+1,000
+145% +$744K 0.96% 19
2025
Q2 		$538K Hold
690
– – 0.32% 107
2025
Q1 		$570K Buy
+690
New +$574K 0.41% 83

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corient IA's LLY Position: Q2 2026 in Review

Corient IA increased its Eli Lilly (LLY) stake by 149% in Q2 2026, buying an estimated $1.02M and bringing the position to 1,670 shares worth $2M. The position accounts for 1.85% of the portfolio, ranked #7.

Corient IA first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Corient IA held 1,670 shares of Eli Lilly worth $2M as of Q2 2026.
  • Corient IA bought 1,000 Eli Lilly shares in Q2 2026, an estimated $1.02M.
  • Eli Lilly made up 1.85% of Corient IA's portfolio in Q2 2026, its #7 holding.
  • Corient IA first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.